Sean F. Scanlan - 08 Mar 2024 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief Innovation Officer
Signature
/s/ Lisa O. Taylor as Attorney in Fact for Sean Scanlan
Issuer symbol
TMCI
Transactions as of
08 Mar 2024
Net transactions value
$0
Form type
4
Filing time
12 Mar 2024, 21:30:12 UTC
Previous filing
12 Jan 2024
Next filing
09 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Tax liability $0 -389 -0.4% $0.000000 96,820 08 Mar 2024 Direct F1
transaction TMCI Common Stock Tax liability $0 -1,396 -1.4% $0.000000 95,424 10 Mar 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 95,681 restricted stock units.
F2 Includes 94,285 restricted stock units.